Search Results - "Mohanakumar, Kochupurackal P"
-
1
Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson’s Disease
Published in Molecular neurobiology (01-01-2018)“…Since substantia nigra (SN) and ventral tegmental area (VTA) dopaminergic neurons are, respectively, susceptible or largely unaffected in Parkinson’s disease…”
Get full text
Journal Article -
2
Quercetin Improves Behavioral Deficiencies, Restores Astrocytes and Microglia, and Reduces Serotonin Metabolism in 3‐Nitropropionic Acid‐Induced Rat Model of Huntington's Disease
Published in CNS neuroscience & therapeutics (01-01-2014)“…Summary Aim Huntington's disease (HD) is an autosomal dominant disorder, for which clinically available drugs offer only symptomatic relief. These prescription…”
Get full text
Journal Article -
3
Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents
Published in Journal of pineal research (01-11-2009)“…: We tested the hypothesis that melatonin regulates formation of 6‐hydroxydopamine (6‐OHDA) in the brain and thereby protects animals from dopaminergic…”
Get full text
Journal Article -
4
Quality of life and concerns of parkinson's disease patients and their caregivers during COVID-19 pandemic: An indian study
Published in Annals of the Indian Academy of Neurology (01-07-2022)“…Objectives: Parkinson's disease (PD) patients have suffered during the coronavirus disease 2019 pandemic, with worsening of both motor and nonmotor symptoms…”
Get full text
Journal Article -
5
Mitochondrial Deficits Accompany Cognitive Decline Following Single Bilateral Intracerebroventricular Streptozotocin
Published in Current Alzheimer research (01-09-2015)“…Bilateral intracerebroventricular (ICV) administration of streptozotocin (STZ) causes Alzheimer's disease (AD)-type neurodegeneration in rats. The model is…”
Get more information
Journal Article -
6
Effect of COVID-19 related lockdown on nonmotor symptoms of Parkinson's disease
Published in Annals of the Indian Academy of Neurology (01-01-2022)Get full text
Journal Article -
7
Gender-Specific Effect of 5-HT and 5-HIAA on Threshold Level of Behavioral Symptoms and Sex-Bias in Prevalence of Autism Spectrum Disorder
Published in Frontiers in neuroscience (08-01-2020)“…Platelet hyperserotonemia in a subset of Autism Spectrum Disorder (ASD) probands, efficacy of selective serotonin reuptake inhibitors (SSRIs) in reducing…”
Get full text
Journal Article -
8
Attention deficit-hyperactivity disorder suffers from mitochondrial dysfunction
Published in BBA clinical (01-12-2016)“…Pathophysiology of attention-deficit hyperactivity disorder (ADHD) is not known, and therefore the present study investigated mitochondrial defects, if any in…”
Get full text
Journal Article -
9
Engraftment of mouse embryonic stem cells differentiated by default leads to neuroprotection, behaviour revival and astrogliosis in parkinsonian rats
Published in PloS one (12-09-2013)“…We report here protection against rotenone-induced behavioural dysfunction, striatal dopamine depletion and nigral neuronal loss, following intra-striatal…”
Get full text
Journal Article -
10
Pilot study indicate role of preferentially transmitted monoamine oxidase gene variants in behavioral problems of male ADHD probands
Published in BMC medical genetics (05-10-2017)“…Attention deficit hyperactivity disorder (ADHD) is an etiologically complex childhood onset neurobehavioral disorder characterized by age-inappropriate…”
Get full text
Journal Article -
11
Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease
Published in Brain research (12-07-2005)“…We examined in Sprague–Dawley rats whether intranigral administration of complex-I inhibitor, rotenone, produces biochemical lesions in the striatum similar to…”
Get full text
Journal Article -
12
Embryonic stem cells derived neuron transplantation recovery in models of parkinsonism in relation to severity of the disorder in rats
Published in Rejuvenation research (01-04-2015)“…6-Hydroxydopamine (6-OHDA)- and 1-methyl-4-phenylpyridinium (MPP(+))-induced hemi-parkinsonism was investigated in relation to the severity of the disorder in…”
Get more information
Journal Article -
13
Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: A comparative study in two mouse strains
Published in Behavioural brain research (08-09-2005)“…Parkinson's disease (PD) is a common neurodegenerative disease that exhibits motor dysfunctions, such as tremor, akinesia and rigidity. In the present study,…”
Get full text
Journal Article -
14
Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson’s Disease?
Published in Molecular neurobiology (2018)“…Parkinson’s disease (PD) has no known cure; available therapies are only capable of offering temporary, symptomatic relief to the patients. Varied therapeutic…”
Get full text
Journal Article -
15
Efficacy of defensins as neutralizing agents against the deadly SARS-CoV-2
Published in Journal of biomolecular structure & dynamics (03-05-2023)“…SARS-CoV-2 infection causes asymptomatic to severe human respiratory diseases. Vaccinations are effective only to a certain extent, and the disease recurs with…”
Get full text
Journal Article -
16
The light at the end of the tunnel gets vivid for spinal muscular atrophy: An Editorial Highlight for "Cerebrospinal fluid proteomic profiling in nusinersen-treated patients with spinal muscular atrophy" on page 650
Published in Journal of neurochemistry (01-06-2020)“…Kessler et al. in this current issue have attempted to discern biomarker(s) for spinal muscular atrophy (SMA) by assessing alterations in cerebrospinal fluid…”
Get full text
Journal Article -
17
Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice
Published in Neurochemistry international (01-10-2016)“…Parkinson’s disease (PD), the most common progressive neurodegenerative movement disorder, results from loss of dopaminergic neurons of substantia nigra pars…”
Get full text
Journal Article -
18
Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
Published in Journal of pineal research (01-04-2015)“…L‐3,4‐dihydroxyphenylalanine (L‐DOPA) reduces symptoms of Parkinson's disease (PD), but suffers from serious side effects on long‐term use. Melatonin…”
Get full text
Journal Article -
19
Tea and Parkinson's disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits
Published in Neurochemistry international (01-10-2015)“…The major neurodegenerative movement disorder Parkinson's disease (PD) is characterized by rest-tremor, akinesia, rigidity and inability to initiate movements…”
Get full text
Journal Article -
20
Serotonin mediated immunoregulation and neural functions: Complicity in the aetiology of autism spectrum disorders
Published in Neuroscience and biobehavioral reviews (01-08-2015)“…Serotonergic system has long been implicated in the aetiology of autism spectrum disorders (ASD), since platelet hyperserotonemia is consistently observed in a…”
Get full text
Journal Article